Olmesartan-based therapies: An effective way to improve blood pressure control and cardiovascular protection

Alejandro De La Sierra, Massimo Volpe

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The main purpose in hypertension treatment is the reduction of cardiovascular disease burden. Among different first-line antihypertensive drug classes, angiotensin-receptor blockers are characterized by their both good effectiveness and tolerability. Furthermore, the interruption of the renin-angiotensin cascade is related with several benefits in target organ protection and cardiovascular prevention. Among different angiotensin-receptor blockers, olmesartan has been examined in several trial of organ protection, showing improvements in several disease markers, such as microinflammation, regression of both plaque volume and vascular hypertrophy, as well as microalbuminuria prevention. Olmesartan has been also widely examined in combination of either hydrochlorothiazide or amlodipine, as well as with both drugs in a single-pill triple combination, showing improvements in antihypertensive efficacy without significant effects on tolerability. This treatment strategy based on a drug with such characteristics and the availability of different types of combinations with other first-line drug classes may represent an effective way for achieving blood pressure control in a majority of hypertensive patients and this could also be related with a better cardiovascular disease prevention.

Original languageEnglish
JournalJournal of Hypertension
Volume31
Issue numberSUPPL. 1
DOIs
Publication statusPublished - Mar 2013

Fingerprint

Angiotensin Receptor Antagonists
Blood Pressure
Antihypertensive Agents
Cardiovascular Diseases
Pharmaceutical Preparations
Amlodipine
Hydrochlorothiazide
Angiotensins
Renin
Hypertrophy
Blood Vessels
Therapeutics
Hypertension
olmesartan

Keywords

  • angiotensin receptor blockers
  • antihypertensive treatment
  • fixed dose combination
  • olmesartan
  • target organ protection

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Olmesartan-based therapies : An effective way to improve blood pressure control and cardiovascular protection. / De La Sierra, Alejandro; Volpe, Massimo.

In: Journal of Hypertension, Vol. 31, No. SUPPL. 1, 03.2013.

Research output: Contribution to journalArticle

@article{5d867852529f4e169ca9b62f422f52b2,
title = "Olmesartan-based therapies: An effective way to improve blood pressure control and cardiovascular protection",
abstract = "The main purpose in hypertension treatment is the reduction of cardiovascular disease burden. Among different first-line antihypertensive drug classes, angiotensin-receptor blockers are characterized by their both good effectiveness and tolerability. Furthermore, the interruption of the renin-angiotensin cascade is related with several benefits in target organ protection and cardiovascular prevention. Among different angiotensin-receptor blockers, olmesartan has been examined in several trial of organ protection, showing improvements in several disease markers, such as microinflammation, regression of both plaque volume and vascular hypertrophy, as well as microalbuminuria prevention. Olmesartan has been also widely examined in combination of either hydrochlorothiazide or amlodipine, as well as with both drugs in a single-pill triple combination, showing improvements in antihypertensive efficacy without significant effects on tolerability. This treatment strategy based on a drug with such characteristics and the availability of different types of combinations with other first-line drug classes may represent an effective way for achieving blood pressure control in a majority of hypertensive patients and this could also be related with a better cardiovascular disease prevention.",
keywords = "angiotensin receptor blockers, antihypertensive treatment, fixed dose combination, olmesartan, target organ protection",
author = "{De La Sierra}, Alejandro and Massimo Volpe",
year = "2013",
month = "3",
doi = "10.1097/HJH.0b013e32835d2b05",
language = "English",
volume = "31",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Olmesartan-based therapies

T2 - An effective way to improve blood pressure control and cardiovascular protection

AU - De La Sierra, Alejandro

AU - Volpe, Massimo

PY - 2013/3

Y1 - 2013/3

N2 - The main purpose in hypertension treatment is the reduction of cardiovascular disease burden. Among different first-line antihypertensive drug classes, angiotensin-receptor blockers are characterized by their both good effectiveness and tolerability. Furthermore, the interruption of the renin-angiotensin cascade is related with several benefits in target organ protection and cardiovascular prevention. Among different angiotensin-receptor blockers, olmesartan has been examined in several trial of organ protection, showing improvements in several disease markers, such as microinflammation, regression of both plaque volume and vascular hypertrophy, as well as microalbuminuria prevention. Olmesartan has been also widely examined in combination of either hydrochlorothiazide or amlodipine, as well as with both drugs in a single-pill triple combination, showing improvements in antihypertensive efficacy without significant effects on tolerability. This treatment strategy based on a drug with such characteristics and the availability of different types of combinations with other first-line drug classes may represent an effective way for achieving blood pressure control in a majority of hypertensive patients and this could also be related with a better cardiovascular disease prevention.

AB - The main purpose in hypertension treatment is the reduction of cardiovascular disease burden. Among different first-line antihypertensive drug classes, angiotensin-receptor blockers are characterized by their both good effectiveness and tolerability. Furthermore, the interruption of the renin-angiotensin cascade is related with several benefits in target organ protection and cardiovascular prevention. Among different angiotensin-receptor blockers, olmesartan has been examined in several trial of organ protection, showing improvements in several disease markers, such as microinflammation, regression of both plaque volume and vascular hypertrophy, as well as microalbuminuria prevention. Olmesartan has been also widely examined in combination of either hydrochlorothiazide or amlodipine, as well as with both drugs in a single-pill triple combination, showing improvements in antihypertensive efficacy without significant effects on tolerability. This treatment strategy based on a drug with such characteristics and the availability of different types of combinations with other first-line drug classes may represent an effective way for achieving blood pressure control in a majority of hypertensive patients and this could also be related with a better cardiovascular disease prevention.

KW - angiotensin receptor blockers

KW - antihypertensive treatment

KW - fixed dose combination

KW - olmesartan

KW - target organ protection

UR - http://www.scopus.com/inward/record.url?scp=84873621950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873621950&partnerID=8YFLogxK

U2 - 10.1097/HJH.0b013e32835d2b05

DO - 10.1097/HJH.0b013e32835d2b05

M3 - Article

C2 - 23389083

AN - SCOPUS:84873621950

VL - 31

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - SUPPL. 1

ER -